News

Vertigo Ventures contribute to Guardian Pharma Roundtable

· Refaela Hsu

[et_pb_section bb_built="1" fullwidth="off" specialty="on"][et_pb_column type="3_4" specialty_columns="3"][et_pb_row_inner admin_label="Row"][et_pb_column_inner type="4_4" saved_specialty_column_type="3_4"][et_pb_image _builder_version="3.0.71" show_in_lightbox="off" url_new_window="off" use_overlay="off" sticky="off" align="left" always_center_on_mobile="on" border_style="solid" force_fullwidth="off" animation="left" src="https://media.hivveimpact.com/wp-content/uploads/2017/09/guardian-pharma-roundtable.png" /][et_pb_post_title title="on" meta="off" author="on" date="on" categories="on" comments="on" featured_image="off" featured_placement="below" parallax_effect="off" parallax_method="on" text_orientation="left" text_color="dark" text_background="off" text_bg_color="rgba(255,255,255,0.9)" use_border_color="off" border_color="#ffffff" border_style="solid" /][et_pb_text background_layout="light" text_orientation="left" border_style="solid" _builder_version="3.0.71" text_font_size_tablet="51" text_line_height_tablet="2" header_font_size_tablet="51" header_line_height_tablet="2"]

Should companies not publish the results of all trials ever done for drugs that went into use?, asked Bokani Tshidzu, of Vertigo Ventures. Sir Peter Dixon, the chair of Diabetes UK, agreed, warning that people will not believe that drug firms have changed "until everything is out there".

[/et_pb_text][/et_pb_column_inner][/et_pb_row_inner][/et_pb_column][et_pb_column type="1_4"][et_pb_contact_form captcha="on" use_redirect="off" input_border_radius="0" use_border_color="off" border_color="#ffffff" border_style="solid" custom_button="off" button_letter_spacing="0" button_use_icon="default" button_icon_placement="right" button_on_hover="on" button_letter_spacing_hover="0" module_class="contactstyle"] [et_pb_contact_field field_title="Name" field_type="input" field_id="Name" required_mark="on" fullwidth_field="on" form_field_font_select="default" form_field_font="||||" use_border_color="off" border_style="solid" /][et_pb_contact_field field_title="Email Address" field_type="email" field_id="Email" required_mark="on" fullwidth_field="on" form_field_font_select="default" form_field_font="||||" use_border_color="off" border_style="solid" /][et_pb_contact_field field_title="Message" field_type="text" field_id="Message" required_mark="on" fullwidth_field="on" /][et_pb_contact_field field_id="Phone" field_title="Phone" field_type="input" required_mark="on" fullwidth_field="on" form_field_font_select="default" form_field_font="||||" use_border_color="off" border_style="solid" /] [/et_pb_contact_form][/et_pb_column][/et_pb_section]

LOGIN:

AI Report top-ups

Impact Tracker - Professional

Impact Tracker - Essential

Impact Reviewer Licence

AI Report top-ups

Get to know Hivve

Explore our latest magazine packed with company news, customer stories, expert insights, new product features, and the ideas shaping the future of impact management.

What Happens Next?
After submitting this form, you’ll receive an email containing a secure payment link. Once payment has been completed, we’ll activate your beta access and send instructions on how to get started.